Skip to main content

Table 5 Reclassification and discrimination results associated with the risk prediction of incident type 2 diabetes according to each measure

From: The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans

Parameter

Men

Women

AROC

p-value*

cNRI

p-value

IDI

p-value

AROC

p-value*

cNRI

p-value

IDI

p-value

Basic modela)

0.615

     

0.621

     

Basic model + WC

0.619

0.1176

0.056

0.1689

0.002

0.0140

0.621

0.3233

−0.023

0.5666

0.000

1.0000

Basic model + TG

0.632

<.0001

0.227

<.0001

0.007

<.0001

0.652

<.0001

0.286

<.0001

0.019

<.0001

Basic model + FPG

0.692

<.0001

0.480

<.0001

0.064

<.0001

0.652

<.0001

0.214

<.0001

0.018

<.0001

Basic model + LAP

0.634

<.0001

0.236

<.0001

0.007

<.0001

0.644

<.0001

0.213

<.0001

0.016

<.0001

Basic model + TyG index

0.656

<.0001

0.387

<.0001

0.023

<.0001

0.666

<.0001

0.360

<.0001

0.029

<.0001

  1. a)Basic model: age, body mass index, status of hypertension, family history of diabetes, smoking status, alcohol consumption, and regular exercise
  2. *P-value for AROC means vs. Basic model
  3. Abbreviations: AROC area under the receiver operating characteristic curve, WC waist circumference, TG triglycerides, LAP lipid accumulation product, TyG index the product of fasting glucose and triglycerides, cNRI continuous net reclassification improvement, IDI Integrated Discrimination Improvement
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us